BRIEF published on 10/10/2024 at 15:19, 1 month 12 days ago The Vanguard Group Discloses 5.45% Stake in Britvic plc Shares Disclosure Takeover Code Vanguard Britvic
PRESS RELEASE published on 10/10/2024 at 15:14, 1 month 12 days ago Form 8.3 - The Vanguard Group, Inc.: Britvic plc The Vanguard Group, Inc. discloses 5.45% ownership in Britvic plc with 13,576,153 securities. Purchase of 34,320 securities at 12.80 GBP per unit Britvic Plc The Vanguard Group Ownership Disclosure Financial Disclosure Securities Purchase
BRIEF published on 10/10/2024 at 10:21, 1 month 12 days ago Barclays Increases Voting Rights in Britvic PLC Voting Rights Britvic Plc Shareholding Equity Swap Barclays PLC
PRESS RELEASE published on 10/10/2024 at 10:16, 1 month 12 days ago Holding(s) in Company Barclays PLC has notified a total of 5.49% of voting rights in Britvic Plc (BVIC) through Barclays Capital Securities Limited on 7-Oct-2024 Voting Rights Britvic Plc BVIC Notification Barclays PLC
BRIEF published on 10/10/2024 at 09:35, 1 month 12 days ago Societe Generale Reduces Stake in Britvic Plc Voting Rights Société Générale Regulatory Filing Shareholder Notification Britvic
PRESS RELEASE published on 10/10/2024 at 09:30, 1 month 12 days ago Holding(s) in Company Societe Generale notifies acquisition of voting rights in Britvic plc (BVIC) on 08-Oct-2024. Total voting rights held: 4.300600% Acquisition Voting Rights Société Générale Britvic Plc BVIC
BRIEF published on 10/09/2024 at 15:06, 1 month 13 days ago Vanguard Group Discloses Stake in Britvic plc Securities Britvic Plc Takeover Code Vanguard Group Stake Disclosure
PRESS RELEASE published on 10/09/2024 at 15:01, 1 month 13 days ago Form 8.3 - The Vanguard Group, Inc.: Britvic plc The Vanguard Group, Inc. discloses a 5.44% interest in Britvic plc's 20p ordinary securities through Form 8.3 filing on 09-Oct-2024 Form 8.3 Britvic Plc The Vanguard Group Securities Disclosure Interest Disclosure
BRIEF published on 10/08/2024 at 15:18, 1 month 14 days ago Vanguard Group Discloses Significant Stake in Britvic Britvic Plc Investment Takeover Code Vanguard Group Shareholding
PRESS RELEASE published on 10/08/2024 at 15:13, 1 month 14 days ago Form 8.3 - The Vanguard Group, Inc.: Britvic plc The Vanguard Group, Inc. discloses a 5.44% stake in Britvic plc as of 07 October 2024. Purchased 4,395 20p ordinary shares at 12.75 GBP per unit The Vanguard Group, Inc. Britvic Plc Stake Disclosure Purchases 20p Ordinary Shares
Published on 11/22/2024 at 16:00, 1 hour 41 minutes ago Manimal Tales Unveils Two New Personalized Christmas-Themed Books to Spread Holiday Magic and Joy!
Published on 11/22/2024 at 15:55, 1 hour 46 minutes ago Independent Proxy Advisory Firm ISS Recommends Signal Gold Shareholders Vote for Arrangement Resolution and Private Placement Resolution
Published on 11/22/2024 at 15:15, 2 hours 26 minutes ago Xenetic Biosciences, Inc. Releases Virtual Investor "What This Means" Segment
Published on 11/22/2024 at 14:45, 2 hours 56 minutes ago Jaguar Health Seeking Partner to Develop and Commercialize NP300 Second-Generation Antisecretory Prescription Drug Candidate for Treatment of General Diarrhea in Dogs
Published on 11/22/2024 at 14:30, 3 hours 11 minutes ago Allied Universal Named Presenting Sponsor of 2024 Lott IMPACT Trophy Recognizing College Football's Defensive Best
Published on 11/22/2024 at 16:00, 1 hour 41 minutes ago Proposed cancellation of admission to trading
Published on 11/22/2024 at 16:00, 1 hour 41 minutes ago AlphaX Makes Crypto Easier with Email Login and USDT Memecoins
Published on 11/22/2024 at 15:27, 2 hours 14 minutes ago EQS-Adhoc: Eckert & Ziegler raises its forecast for the current financial year once again
Published on 11/22/2024 at 14:46, 2 hours 54 minutes ago Form 8.3 - The Vanguard Group, Inc.: International Paper Company
Published on 11/21/2024 at 06:58, 1 day 10 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 1 day 22 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 1 day 23 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 1 day 23 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
